VISIOMED GROUP overview

Visiomed Group announces a new footfall record for its Smart Salem centers during the first quarter of 2024 Volume growth of +31% for Q1 2024, despite the start of the month of Ramadan and its slowdown impact on all business sectors across the United Arab Emirates Continued strong growth for the Medical Fitness segment (+29%) The Wellness Tests segment continues to ramp-up Paris, April 4, 2024 VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and...

+38% revenue growth vs. 2022 on a normalized basis €3.5 million normalized EBITDA (25% EBITDA margin), and €2.2 million consolidated EBITDA (+€4.3 million vs. 2022) €1.1 million normalized Net Income (8% net margin), and -€1.1 million consolidated Net Income (+€4.2 million vs. 2022) A strong balance sheet with higher cash balance and debt under control Strong growth also expected for 2024 with further revenue diversification as well as the expansion in Saudi Arabia Paris, Dubai,...

+38% sales growth in 2023 compared with 2022 Medical Fitness activities continued to grow strongly during the year Successful diversification of revenues with the launch of the new "Wellness tests" offering Strong growth also expected for 2024 with further revenue diversification as well as the expansion in Saudi Arabia Paris, February 13, 2024 VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and services, presents its unaudited sales figures for...

More than 13,504 tests performed in January 2024 An average of 614 tests per day Volume growth of +34% compared with January 2023 Paris, February 1, 2024 VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and services, announces a new footfall record in January 2024 for its Smart Salem subsidiary. Following a strong growth in 2023 (+41% in volume compared with 2022), Smart Salem confirms its excellent start of the 2024 financial year as it welcomed...

Paris, January 22, 2024 VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and services, announces the appointment of Clément Pacaud as the Chief Executive Officer of the Group. At 34 years old, Clément brings over 12 years of experience, with 10 years spent in the Gulf countries, overseeing businesses, driving financial and operational strategies, managing acquisitions, structuring complex international joint ventures, and guiding high-growth...

38% growth in the number of tests performed in Q4 2023 Continued strong growth for the Medical Fitness segment (+35%) in Q4 2023 41% growth in the number of tests performed over the full year 2023 Positive start for the Wellness Tests segment Paris, January 8, 2024 VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and services, releases Smart Salem's trading update for the 4 th quarter of 2023. Smart Salem operates the first network of fully digital...

Paris, January 2, 2024 VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and services, announces a strategic milestone in the deployment of its activities in Saudi Arabia. The Group, via its subsidiary Smart Health, has just secured a prime location for its 1 st medical center of over 600 square meters in the heart of Riyadh's dynamic financial district: King Abdullah Financial District (KAFD). The new center will offer the Group's unique know-how,...

Over 12,600 tests performed in October 2023 An average of 574 tests per day Volume growth of +56% versus October 2022 Paris, November 3 rd , 2023 VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and services, publishes a record month in terms of tests conducted at its Smart Salem subsidiary in October 2023. After a 34% volume growth in the 1 st half of 2023 [1] and a 60% growth in the 3 rd quarter of 2023 [2] , Smart Salem confirms its momentum by...